Rebecca C Brady
Affiliation: Cincinnati Children's Hospital Medical Center
- InfluenzaRebecca C Brady
Division of Pediatric Infectious Diseases, Department of Pediatrics, Cincinnati Children s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
Adolesc Med State Art Rev 21:236-50, viii. 2010..Recommendations for use of the inactivated and live attenuated vaccines against seasonal influenza and against the 2009 novel H1N1 influenza viruses are reviewed...
- Comparison of antibody and T-cell responses elicited by licensed inactivated- and live-attenuated influenza vaccines against H3N2 hemagglutininSaleem Basha
Cincinnati Children s Hospital Medical Center, Division of Infectious Diseases, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Hum Immunol 72:463-9. 2011..These results have important implications for the deployment of influenza vaccines in years of antigenic mismatch and shift...
- Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States childrenRebecca C Brady
Cincinnati Children s Hospital Medical Center, Cincinnati, OH, United States Electronic address
Vaccine 32:7141-7. 2014..49 vs. 382.45 for H1N1; 669.13 vs. 705.61 for H3N2; and 100.65 vs. 93.72 for B. CSL's TIV demonstrated immunological non-inferiority to the established vaccine in all cohorts...
- Treatment of herpes simplex virus infectionsRebecca C Brady
Cincinnati Children s Hospital Medical Center, Division of Infectious Diseases, 3333 Burnet Avenue, Mail Location 6014, Cincinnati, OH 45229 3039, USA
Antiviral Res 61:73-81. 2004..This article will review the common presentations for HSV disease and the current recommendations for the treatment of these infections. A detailed summary of the antiviral drugs used to treat HSV infections is also presented...
- Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adultsRebecca C Brady
Cincinnati Children s Hospital Medical Center, OH 45229 3039, United States
Vaccine 27:5091-5. 2009..Antibody responses to the vaccine were not enhanced by AlOH at any HA dose level. A microneutralization titer > or =40 was observed in 36% and 40% of subjects who received 45microg of HA with or without AlOH, respectively...
- Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutininRamu A Subbramanian
Cincinnati Children s Hospital Medical Center, Division of Infectious Diseases, Department of Pediatrics, Cincinnati, Ohio, USA
Hum Immunol 71:957-63. 2010..These results have important ramifications for our understanding of influenza immunity in humans and development of vaccine strategies against this important pathogen...
- Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adultsRobert W Frenck
Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
Vaccine 29:5666-74. 2011..The reduced 3 μg dose administered ID by needle and syringe, as well as the 6 μg ID for subjects aged 50-64 years of age generated poorer immune responses as compared to the 15 μg IM dose...
- Comparison of the immunogenicity of intramuscular versus subcutaneous administration of trivalent inactivated influenza vaccine in individuals with neuromuscular diseasesMarjorie C Golekoh
Department of Pediatrics, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
J Child Neurol 28:596-601. 2013..5) between intramuscular and subcutaneous routes. Seroprotection was not adversely affected by glucocorticoid therapy. Local tolerance was better with subcutaneous route. Larger studies are needed to confirm these preliminary results...
- Factors predicting the acceptance of herpes simplex virus type 2 antibody testing among adolescents and young adultsGregory D Zimet
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA
Sex Transm Dis 31:665-9. 2004..The rates and determinants of acceptance of herpes simplex virus type 2 (HSV-2) testing have not been adequately studied...
- Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccinationRamu A Subbramanian
Cincinnati Children s Hospital Medical Center, Division of Infectious Diseases, Department of Pediatrics, Cincinnati, OH, USA
Vaccine 28:8258-67. 2010..Cross reactive T cell responses to the pandemic H1N1 HA existed among the cohort before the circulation of the virus to varying degrees and these responses were boosted by seasonal vaccination...
- Oral acyclovir suppression and neurodevelopment after neonatal herpesDavid W Kimberlin
Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA
N Engl J Med 365:1284-92. 2011..Poor neurodevelopmental outcomes and recurrences of cutaneous lesions remain unacceptably frequent among survivors of neonatal herpes simplex virus (HSV) disease...